Coordination of Transcription Factor Phosphorylation and Histone Methylation by the P-TEFb Kinase during Human Immunodeficiency Virus Type 1 Transcription

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Virology

• Publication date

  2004-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.78.24.13522-13533.2004PMID 15564463PMCID PMC533906
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methylation of Histone H3 by Set2 in Saccharomyces cerevisiae Is Linked to Transcriptional Elongation by RNA Polymerase II

  2003influential reference
• The Set2 Histone Methyltransferase Functions through the Phosphorylated Carboxyl-terminal Domain of RNA Polymerase II*

  2003influential reference
• RNA polymerase II accumulation in the promoter-proximal region of the dihydrofolate reductase and gamma-actin genes.

  2003cited by this paper
• Methylation of SPT5 regulates its interaction with RNA polymerase II and transcriptional elongation properties.

  2003cited by this paper
• Phosphorylation of RNA polymerase II CTD regulates H3 methylation in yeast.

  2003cited by this paper
• Transcriptional Elongation by RNA Polymerase II and Histone Methylation*

  2003cited by this paper
• The Tat/TAR-dependent phosphorylation of RNA polymerase II C-terminal domain stimulates cotranscriptional capping of HIV-1 mRNA

  2003cited by this paper
• Tails of intrigue: phosphorylation of RNA polymerase II mediates histone methylation.

  2003cited by this paper
• Targeted recruitment of Set1 histone methylase by elongating Pol II provides a localized mark and memory of recent transcriptional activity.

  2003cited by this paper
• RNA Polymerase II Accumulation in the Promoter-Proximal Region of the Dihydrofolate Reductase and γ-Actin Genes

  2003cited by this paper
• Thymidine phosphorylase and dihydropyrimidine dehydrogenase levels in primary colorectal cancer show a relationship to clinical effects of 5'-deoxy-5-fluorouridine as adjuvant chemotherapy.

  2002cited by this paper
• Association of the Histone Methyltransferase Set2 with RNA Polymerase II Plays a Role in Transcription Elongation*

  2002cited by this paper
• Spt5 Cooperates with Human Immunodeficiency Virus Type 1 Tat by Preventing Premature RNA Release at Terminator Sequences

  2002cited by this paper
• Integrating mRNA processing with transcription.

  2002cited by this paper
• Regulation of transcription elongation by phosphorylation.

  2002cited by this paper
• CDK-9/cyclin T (P-TEFb) is required in two postinitiation pathways for transcription in the C. elegans embryo.

  2002cited by this paper
• Structural basis for inhibition of cyclin-dependent kinase 9 by flavopiridol.

  2002cited by this paper
• Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation.

  2002cited by this paper
• Phosphorylation of the RNA Polymerase II Carboxyl-Terminal Domain by CDK9 Is Directly Responsible for Human Immunodeficiency Virus Type 1 Tat-Activated Transcriptional Elongation

  2002cited by this paper
• Suppression of HIV-1 expression by inhibitors of cyclin-dependent kinases promotes differentiation of infected podocytes.

  2001cited by this paper
• Positive Transcription Elongation Factor b Phosphorylates hSPT5 and RNA Polymerase II Carboxyl-terminal Domain Independently of Cyclin-dependent Kinase-activating Kinase*

  2001cited by this paper
• Inhibition of Human Immunodeficiency Virus Type 1 Transcription by Chemical Cyclin-Dependent Kinase Inhibitors

  2001cited by this paper
• DSIF and NELF Interact with RNA Polymerase II Elongation Complex and HIV-1 Tat Stimulates P-TEFb-mediated Phosphorylation of RNA Polymerase II and DSIF during Transcription Elongation*

  2001cited by this paper
• Flavopiridol Inactivates P-TEFb and Blocks Most RNA Polymerase II Transcription in Vivo *

  2001cited by this paper
• TFIIH Inhibits CDK9 Phosphorylation during Human Immunodeficiency Virus Type 1 Transcription*

  2001cited by this paper
• Domains in the SPT5 Protein That Modulate Its Transcriptional Regulatory Properties

  2000cited by this paper
• CDK9 Autophosphorylation Regulates High-Affinity Binding of the Human Immunodeficiency Virus Type 1 Tat–P-TEFb Complex to TAR RNA

  2000cited by this paper
• Kin28, the TFIIH-Associated Carboxy-Terminal Domain Kinase, Facilitates the Recruitment of mRNA Processing Machinery to RNA Polymerase II

  2000cited by this paper
• Relief of Two Built-In Autoinhibitory Mechanisms in P-TEFb Is Required for Assembly of a Multicomponent Transcription Elongation Complex at the Human Immunodeficiency Virus Type 1 Promoter

  2000cited by this paper
• Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription.

  2000influential reference
• P-TEFb, a Cyclin-Dependent Kinase Controlling Elongation by RNA Polymerase II

  2000cited by this paper
• Spt5 and spt6 are associated with active transcription and have characteristics of general elongation factors in D. melanogaster.

  2000cited by this paper
• Flavopiridol Inhibits P-TEFb and Blocks HIV-1 Replication*

  2000cited by this paper
• Tat Modifies the Activity of CDK9 To Phosphorylate Serine 5 of the RNA Polymerase II Carboxyl-Terminal Domain during Human Immunodeficiency Virus Type 1 Transcription

  2000influential reference
• Dynamic association of capping enzymes with transcribing RNA polymerase II.

  2000cited by this paper
• Roscovitine, a Specific Inhibitor of Cellular Cyclin-Dependent Kinases, Inhibits Herpes Simplex Virus DNA Synthesis in the Presence of Viral Early Proteins

  2000cited by this paper
• High-resolution localization of Drosophila Spt5 and Spt6 at heat shock genes in vivo: roles in promoter proximal pausing and transcription elongation.

  2000cited by this paper
• Tat Activates Human Immunodeficiency Virus Type 1 Transcriptional Elongation Independent of TFIIH Kinase

  1999cited by this paper
• Cyclin T1 domains involved in complex formation with Tat and TAR RNA are critical for tat-activation.

  1999cited by this paper
• Virus infection leads to localized hyperacetylation of histones H3 and H4 at the IFN-beta promoter.

  1999cited by this paper
• Distinct roles for CTD Ser-2 and Ser-5 phosphorylation in the recruitment and allosteric activation of mammalian mRNA capping enzyme.

  1999cited by this paper
• Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation.

  1999cited by this paper
• Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T.

  1999cited by this paper
• Role of the human and murine cyclin T proteins in regulating HIV-1 tat-activation.

  1999cited by this paper
• Evidence that P‐TEFb alleviates the negative effect of DSIF on RNA polymerase II‐dependent transcription in vitro

  1998cited by this paper
• Characterization of the Residues Phosphorylated in Vitro by Different C-terminal Domain Kinases*

  1998cited by this paper
• DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs.

  1998cited by this paper
• PITALRE, the Catalytic Subunit of TAK, Is Required for Human Immunodeficiency Virus Tat Transactivation In Vivo

  1998cited by this paper
• Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV‐1 Tat

  1998cited by this paper
• Transcription elongation factor P‐TEFb mediates Tat activation of HIV‐1 transcription at multiple stages

  1998cited by this paper
• The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein.

  1998cited by this paper
• A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA.

  1998cited by this paper
• Transcriptional control: Tat cofactors and transcriptional elongation.

  1998cited by this paper
• Identification of multiple cyclin subunits of human P-TEFb.

  1998cited by this paper
• The Cyclin E Promoter Is Activated by Human Cytomegalovirus 86-kDa Immediate Early Protein*

  1998cited by this paper
• Purification of a Tat‐associated kinase reveals a TFIIH complex that modulates HIV‐1 transcription

  1997cited by this paper
• Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro.

  1997cited by this paper
• P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro.

  1997cited by this paper
• The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II.

  1997cited by this paper
• TAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines.

  1997cited by this paper
• Analysis of chromatin structure by in vivo formaldehyde cross-linking.

  1997cited by this paper
• The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function

  1996cited by this paper
• Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain

  1996cited by this paper
• Requirements for RNA Polymerase II Carboxyl-terminal Domain for Activated Transcription of Human Retroviruses Human T-Cell Lymphotropic Virus I and HIV-1*

  1996cited by this paper
• Reversible Phosphorylation of the C-terminal Domain of RNA Polymerase II*

  1996cited by this paper
• Control of RNA Polymerase II Elongation Potential by a Novel Carboxyl-terminal Domain Kinase*

  1996cited by this paper
• Tat-SF1: Cofactor for Stimulation of Transcriptional Elongation by HIV-1 Tat

  1996cited by this paper
• Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II.

  1996cited by this paper
• Purification of P-TEFb, a Transcription Factor Required for the Transition into Productive Elongation (*)

  1995cited by this paper
• Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor

  1995cited by this paper
• The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor.

  1994cited by this paper
• Human immunodeficiency virus type 1 RNA expression by four chronically infected cell lines indicates multiple mechanisms of latency

  1994cited by this paper
• Induction of developmentally programmed cell death and activation of HIV by sodium butyrate.

  1994cited by this paper
• Specific interaction of the human immunodeficiency virus Tat proteins with a cellular protein kinase.

  1993cited by this paper
• Control of formation of two distinct classes of RNA polymerase II elongation complexes

  1992cited by this paper
• Sequences within the R region of the long terminal repeat activate basal transcription from the HIV-1 promoter.

  1992cited by this paper
• Fragments of the HIV-1 Tat protein specifically bind TAR RNA.

  1990cited by this paper
• Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro.

  1989cited by this paper
• Tat trans-activates the human immunodeficiency virus through a nascent RNA target.

  1989cited by this paper
• Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product

  1987cited by this paper

• NVP-2, in combination with Orlistat, represents a promising therapeutic strategy for acute myeloid leukemia

  2025cites this paper
• Transcriptional Stochasticity as a Key Aspect of HIV-1 Latency

  2023cites this paper
• HIV-1 Gag colocalizes with euchromatin histone marks at the nuclear periphery

  2023cites this paper
• HIV-1 Gag co-localizes with euchromatin histone marks at the nuclear periphery

  2023cites this paper
• Cannabinoids Reduce Extracellular Vesicle Release from HIV-1 Infected Myeloid Cells and Inhibit Viral Transcription

  2022cites this paper
• Structure, Activity and Function of the NSD3 Protein Lysine Methyltransferase

  2021cites this paper
• Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approach

  2021cites this paper
• In Vitro Antiviral Activity of Mentha cordifolia Plant Extract in HIV-1 Latently Infected Cells Using an Established Human Cell Line

  2021cites this paper
• In search of therapeutic candidates for HIV/AIDS: rational approaches, design strategies, structure–activity relationship and mechanistic insights

  2021cites this paper
• Computational prediction and analysis of histone H3k27me1-associated miRNAs.

  2020cites this paper
• Genetic and epigenetic regulation of natural resistance to HIV-1 infection: new approaches to unveil the HESN secret

  2020cites this paper
• A CRISPR/Cas9 screen identifies the histone demethylase MINA53 as a novel HIV-1 latency-promoting gene (LPG)

  2019cites this paper
• Transcription-associated histone modifications & cryptictranscription

  2018cites this paper
• Chromatin Regulation and the Histone Code in HIV Latency


  2017cites this paper
• Impact of Chromatin on HIV Replication

  2015cites this paper
• BRCA1 functions as a novel transcriptional cofactor in HIV-1 infection

  2015cites this paper
• Role of Bruton’s tyrosine kinase inhibitors in HIV-1-infected cells

  2015cites this paper
• Dual Role of Novel Ingenol Derivatives from Euphorbia tirucalli in HIV Replication: Inhibition of De Novo Infection and Activation of Viral LTR

  2014cites this paper
• Transcription Through Chromatin

  2014cites this paper
• Inhibition of Post-Transcriptional RNA Processing by CDK Inhibitors and Its Implication in Anti-Viral Therapy

  2014cites this paper
• Fundamentals of Chromatin

  2014cites this paper
• Transcription-associated histone modifications and cryptic transcription.

  2013cites this paper
• Dynamic histone H 3 methylation during gene induction : HYPB / Setd 2 mediates all H 3 K 36 trimethylation

  2013cites this paper
• Tip110 Protein Binds to Unphosphorylated RNA Polymerase II and Promotes Its Phosphorylation and HIV-1 Long Terminal Repeat Transcription*

  2013cites this paper
• Use of ATP analogs to inhibit HIV-1 transcription.

  2012cites this paper
• Impact of sustained RNAi-mediated suppression of cellular cofactor Tat-SF1 on HIV-1 replication in CD4+ T cells

  2012cites this paper
• Control of HIV Latency by Epigenetic and Non-Epigenetic Mechanisms

  2011cites this paper
• Epigenetic regulation of HIV latency

  2011cites this paper
• Activation of HIV Transcription by the Viral Tat Protein Requires a Demethylation Step Mediated by Lysine-specific Demethylase 1 (LSD1/KDM1)

  2011cites this paper
• Neurotoxicity of Human Immunodeficiency Virus-1: Viral Proteins and Axonal Transport

  2011cites this paper
• HIV-1 replication and latency are regulated by translational control of cyclin T1.

  2011cites this paper
• Varying modulation of HIV-1 LTR activity by Baf complexes.

  2011cites this paper
• Epigenetic Silencing of HIV-1 by the Histone H3 Lysine 27 Methyltransferase Enhancer of Zeste 2

  2011cites this paper
• Tip110 Control of HIV-1 Gene Expression and Replication

  2011cites this paper
• Cellular Protein Kinases as Antiviral Targets

  2011cites this paper
• Host factors mediating HIV-1 replication.

  2011cites this paper
• Baf 53 , Baf 170 , and Actin mSin 3 A / HDAC BAF ( A , B ) WINAC NUMAC Chromatin Remodeler with no Baf 53 Chromatin Remodelers

  2011cites this paper
• Varying modulation of HTLV-1 LTR activity by BAF complexes

  2011cites this paper
• Regulation of Cellular and HIV-1 Gene Expression by Positive Transcription Elongation Factor B: A Dissertation

  2010cites this paper
• RNA Genes: Retroelements and Virally Retroposable microRNAs in Human Embryonic Stem Cells

  2010cites this paper
• microRNA machinery is an integral component of drug-induced transcription inhibition in HIV-1 infection

  2010cites this paper
• HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP.

  2010cites this paper
• The Cellular lysine methyltransferase Set7/9-KMT7 binds HIV-1 TAR RNA, monomethylates the viral transactivator Tat, and enhances HIV transcription.

  2010cites this paper
• Selective control of gene expression by CDK9 in human cells

  2010cites this paper
• Tat-SF1 Is Not Required for Tat Transactivation but Does Regulate the Relative Levels of Unspliced and Spliced HIV-1 RNAs

  2009cites this paper
• Investigating the Roles of Tat Specific Factor 1 in Both HIV-1 and Cellular Gene Expression

  2009cites this paper
• Cell-type-specific proteome and interactome: using HIV-1 Tat as a test case

  2009cites this paper
• SKIP interacts with c-Myc and Menin to promote HIV-1 Tat transactivation.

  2009cites this paper
• Insights into the function of the human P-TEFb component CDK9 in the regulation of chromatin modifications and co-transcriptional mRNA processing

  2009cites this paper
• Novel HIV-1 therapeutics through targeting altered host cell pathways

  2009cites this paper
• Effect of transcription peptide inhibitors on HIV-1 replication.

  2008influential citation
• PHD finger of autoimmune regulator: An epigenetic link between the histone modifications and tissue-specific antigen expression in thymus

  2008cites this paper
• The multi-tasking P-TEFb complex.

  2008cites this paper
• The Werner Syndrome Helicase Is a Cofactor for HIV-1 Long Terminal Repeat Transactivation and Retroviral Replication*

  2007cites this paper
• Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation

  2007cites this paper
• Identifying the Membrane Proteome of HIV-1 Latently Infected Cells*

  2007cites this paper
• Nuclear Factor 90(NF90) targeted to TAR RNA inhibits transcriptional activation of HIV-1

  2007cites this paper
• Recruitment and Activation of RSK2 by HIV-1 Tat

  2007cites this paper
• Chromatin regulation of virus infection.

  2006cites this paper
• Will diverse Tat interactions lead to novel antiretroviral drug targets?

  2006cites this paper
• Replication of human immunodeficiency virus type 1 from entry to exit

  2006cites this paper
• Are Viral-Encoded MicroRNAs Mediating Latent HIV-1 Infection?

  2006influential citation
• Potential use of pharmacological cyclin-dependent kinase inhibitors as anti-HIV therapeutics.

  2006cites this paper
• Chromatin modifications (acetylation/ deacetylation/ methylation) as new targets for HIV therapy.

  2006cites this paper
• P-TEFb-mediated phosphorylation of hSpt5 C-terminal repeats is critical for processive transcription elongation.

  2006cites this paper
• Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription

  2006cites this paper
• Inhibition of HIV-1 virus replication using small soluble Tat peptides.

  2006influential citation
• Five Years of Progress on Cyclin-Dependent Kinases and other Cellular Proteins as Potential Targets for Antiviral Drugs

  2006influential citation
• Tax Interacts with P-TEFb in a Novel Manner To Stimulate Human T-Lymphotropic Virus Type 1 Transcription

  2006cites this paper
• Herpes simplex viruses in antiviral drug discovery.

  2006cites this paper
• Indirubin-3′-monoxime, a derivative of a Chinese antileukemia medicine, inhibits P-TEFb function and HIV-1 replication

  2005cites this paper
• Tat gets the "green" light on transcription initiation

  2005cites this paper
• Spatial Distribution of Di- and Tri-methyl Lysine 36 of Histone H3 at Active Genes*

  2005cites this paper
• A human splicing factor, SKIP, associates with P-TEFb and enhances transcription elongation by HIV-1 Tat.

  2005cites this paper
• NF-κB-Repressing Factor Inhibits Elongation of Human Immunodeficiency Virus Type 1 Transcription by DRB Sensitivity-Inducing Factor

  2005cites this paper